drugset / Trial / NCT00784420
Drug Interaction Study Between Raltegravir And UK-453,061
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to estimate the effect of steady state raltegravir on the steady state pharmacokinetics of UK-453,061 and steady state UK-453,061 on the steady state pharmacokinetics of raltegravir.
Timeline
- Start
- 2008-09
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lersivirine | Small molecule | 1000 mg | — |
| Subject | Raltegravir | Other / unclassified | 400 mg | — |
Indications
No indication recorded.